 |
|
Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
February 19, 2008A study from the Jichi Medical University in Japan shows that optimal band imaging used with an endoscope provided images that clearly identified depressed-type early gastric cancer without magnification in 96 percent of study participants. The study appears in the February issue of Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.
Gastric cancer is one of the most prevalent types of cancer in the world. If gastric cancer is found early, the five-year survival rate increases nearly 90 percent. In contrast, most patients with advanced gastric cancer have a poor prognosis. Gastric cancer is classified as elevated, flat and depressed types. Despite improvements in endoscopic technologies, depressed-type early gastric cancer is challenging to diagnose because it manifests as subtle changes in color and shape. Variations in color, however, can also mean inflammation, so it is difficult to determine what is benign and what is malignant. Therefore, biopsies must then be taken.
"In our comparative study, the optimal band imaging system with endoscopy showed contrasting images that could delineate the depressed-type early gastric cancers more easily than conventional endoscopy," said the study's lead author Hiroyuki Osawa, MD, Jichi Medical University. "A distinct demarcation was observed endoscopically between the reddish images of the cancerous lesion and the yellowish images of the surrounding noncancerous area. This is the first report of optimal band images for early gastric cancer."
Optimal band imaging (OBI) was developed with the aim of enhancing the capillary pattern and pit patterns of lesions in endoscopic images. In contrast to narrow band imaging, in which the bandwidth of spectral transmittance is narrowed by optical filters, the OBI system is based on a new spectral estimation technique that replaces the need for optical filters. OBI takes an ordinary endoscopic image from the video processor and arithmetically processes the reflected photons to reconstitute virtual images for a choice of different wavelengths.
Patients and Methods
An OBI system with electronic endoscope for the upper-gastrointestinal tract was used in this prospective study. Twenty-seven patients between May and December 2006 who were diagnosed with conventional endoscopy as having depressed-type early gastric cancer participated in the study. The mean age of the patients was 65.3 years with 23 men and four women. Twenty-four patients were diagnosed with differentiated adenocarcinoma and three patients with undifferentiated adenocarcinoma by the histopathologic evaluation of biopsy specimens. Researchers used the OBI system without magnification to observe the entire stomach because of the ample light intensity.
Results
With the OBI system, depressed type-early gastric cancer in 26 of 27 cases were easily identified because it clearly showed contrasting demarcation lines between the reddish images of the cancerous lesions and the yellowish images of the surrounding noncancerous area. A 40-fold magnification was then applied to observe the pit pattern, the disappearance of pit pattern or an irregular microvascular pattern of the cancerous lesions. This further enhanced the demarcation of the cancer and the noncancerous areas.
Researchers concluded that OBI images were better than conventional endoscopy images in identifying depressed-type early gastric cancer, but said that further study is warranted. They noted that even medical students, who had not had considerable amounts of clinical endoscopic experience, were able to easily identify the demarcation line between cancer and noncancerous areas in optimal band images versus conventional endoscopic images. OBI is available even without magnification during routine endoscopy because the system provides the same light intensity as conventional endoscopy. The researchers stated that such nonmagnified optimal band images may be ideal for screening, whereas magnified optimal band images are more suitable for detailed examination of early gastric cancer.
American Society for Gastrointestinal Endoscopy
Optimal band imaging (OBI) was developed with the aim of enhancing the capillary pattern and pit patterns of lesions in endoscopic images. In contrast to narrow band imaging, in which the bandwidth of spectral transmittance is narrowed by optical filters, the OBI system is based on a new spectral estimation technique that replaces the need for optical filters. OBI takes an ordinary endoscopic image from the video processor and arithmetically processes the reflected photons to reconstitute virtual images for a choice of different wavelengths.
Patients and Methods
An OBI system with electronic endoscope for the upper-gastrointestinal tract was used in this prospective study. Twenty-seven patients between May and December 2006 who were diagnosed with conventional endoscopy as having depressed-type early gastric cancer participated in the study. The mean age of the patients was 65.3 years with 23 men and four women. Twenty-four patients were diagnosed with differentiated adenocarcinoma and three patients with undifferentiated adenocarcinoma by the histopathologic evaluation of biopsy specimens. Researchers used the OBI system without magnification to observe the entire stomach because of the ample light intensity.
Results
With the OBI system, depressed type-early gastric cancer in 26 of 27 cases were easily identified because it clearly showed contrasting demarcation lines between the reddish images of the cancerous lesions and the yellowish images of the surrounding noncancerous area. A 40-fold magnification was then applied to observe the pit pattern, the disappearance of pit pattern or an irregular microvascular pattern of the cancerous lesions. This further enhanced the demarcation of the cancer and the noncancerous areas.
Researchers concluded that OBI images were better than conventional endoscopy images in identifying depressed-type early gastric cancer, but said that further study is warranted. They noted that even medical students, who had not had considerable amounts of clinical endoscopic experience, were able to easily identify the demarcation line between cancer and noncancerous areas in optimal band images versus conventional endoscopic images. OBI is available even without magnification during routine endoscopy because the system provides the same light intensity as conventional endoscopy. The researchers stated that such nonmagnified optimal band images may be ideal for screening, whereas magnified optimal band images are more suitable for detailed examination of early gastric cancer.
American Society for Gastrointestinal Endoscopy
Gastric Cancer Current Events and Gastric Cancer News RSSAfrican-Americans with colorectal cancer have poorer outcomes, lower survival rates
New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans.
Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis?
Since the isolation and culture of Helicobacter pylori (H. pylori) in 1983, this bacterium has become accepted as an important human pathogen for the development of gastritis, peptic ulcer, and gastric cancer.
A new explanation of 'Asian paradox'
Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains.
Will genomics help prevent the next pandemic?
This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease.
Protein interaction network can respond Helicobacter pylori infection?
Helicobacter pylori (H pylori) is a gram negative bacterium which infects about 50% of the world population. H pylori colonization causes a strong systemic immune response.
A case of post-gastrectomy acute pancreatitis
Gastrectomy is commonly performed for both benign and malignant lesions. Although the incidence of post-gastrectomy acute pancreatitis (PGAP) is low compared to other well-recognized post-operative complications, it has been reported to be associated with a high mortality rate.
Does Helicobacter pylori eradication therapy prevent gastric cancer?
Although it has been demonstrated that Helicobacter pylori causes gastric cancer, it is still controversial that whether H. pylori eradication therapy is effective in primary prevention of gastric cancer.
New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers
Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress.
NIH study reveals new genetic culprit in deadly skin cancer
Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma.
PPAR-g agonists have potential therapeutic role in gastric carcinoma?
Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied.
More Gastric Cancer Current Events and Gastric Cancer News Articles
 |
100 Q&A About Gastric Cancer (100 Questions & Answers about . . .) (100 Questions and Answers) by Manish A. Shah (Author) About 21,700 Americans are diagnosed with stomach cancer each year and it occurs most often in people in their 60s and 70s. Whether you're a newly diagnosed patient with gastric cancer or a friend or relative of someone with cancer, this book offers help. This book is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease. The author Dr. Shah is from Memorial Sloan-Kettering Cancer Center, one of the few National Cancer Institute-designated cancer centers with a specific program in treating cancers of the upper gastrointestinal tract and has made many of the major advances in the treatment of these diseases. |
 |
Cancer Of The Stomach, A Clinical Study Of 921 Operatively And Pathologically Demonstrated Cases: With A Chapter On The Surgical Treatment Of Gastric Cancer by Frank Smithies (Author), Albert John Ochsner (Contributor) This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature. |
 |
Gastric Cancer by T. Sugimura (Editor), M. Sasako (Editor) The editors have produced a concise and up-to-date account of all aspects of gastric cancer, which is still one of the five major causes of cancer death in most countries of the world today. The book ranges from epidemiology, aetiology, and biology, to surgical and non-surgical treatements and primary and secondary prevention. It summarizes the latest progress in the various fields, as well as providing practical guidance on diagnosis and management, and is written by acknowledged experts in the subject both in the West and Japan. |
 |
The Biology of Gastric Cancers by Timothy C. Wang (Editor), James G. Fox (Editor), Andrew S. Giraud (Editor) The purpose of this work is to provide a general and comprehensive reference work on the biology of gastric cancers for those researchers working in this area. This monograph will be written by a panel of experts in each area and represent the latest work in a series of different areas of gastric cancer research. |
 |
The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis and Therapy by M. Kaminishi (Editor), K. Takubo (Editor), K. Mafune (Editor) Japan has long been a leader of research into the carcinogenesis, pathology, diagnosis, and treatment of gastric carcinoma, which is still the second leading cause of cancer death worldwide. Distinguished experts in the field collaborated in creating this groundbreaking work, providing a comprehensive view of gastric cancer. This book encourages further development of gastric cancer research and its clinical application. Topics include all aspects of gastric carcinoma, such as the history of clinical and experimental gastric cancer research; updated issues of molecular and pathological research on gastric carcinogenesis; multidisciplinary methods in diagnosis, treatment, and chemotherapy; and perspectives in minimally invasive surgery. Color figures of histological specimens and other... |
|
Gastric Cancer by M. Nishi (Author), H. Ichikawa (Author), T. Nakajima (Author), K. Maruyama (Author), E. Tahara (Editor) Cancer Institute Hospital, Tokyo, Japan. Basic science and clinical research on gastric cancer, for oncologists. Includes epidemiology, experimental carcinogenesis, pathology, biology, diagnosis, and treatment. 58 contributors. DNLM: Stomach Neoplasms. | |
|
Endoscopy in gastric cancer (Recent results in cancer research) by Robert S Nelson (Author) | |
|
Multimodality Therapy for Gastric Cancer: Appendix: Database of the Cancer Institute Hospital by Toshifusa Nakajima (Editor), Toshiharu Yamaguchi (Editor), Cancer Institute Hospital (Editor) Recent clinical trials of adjuvant therapy for gastric cancer in Japan have shown improved survival benefits, but the results have been considered controversial and have been viewed with some skepticism in the West. Until now, the efforts of Japanese surgical oncologists in multimodality therapy have not been fully understood because they have not been adequately reported in English. This volume now presents the experience and expertise of Japanese surgeons who utilize preoperative or intraoperative chemotherapy, or a combination of systemic and regional chemotherapy. Their collected work provides valuable insight in the Japanese perspective and success in treating gastric cancer. Included in the appendix is an extensive tabular analysis of the gastric cancer database at the Cancer... | |
|
Early gastric cancer: current status of diagnosis by Springer-Verlag (Publisher) | |
 |
Research Focus on Gastric Cancer by S. M. Abbas (Author), Stefania Boccia (Author), S. Chukov (Author), Domenico D'Ugo (Author), Cecilia Fenoglio-Preiser (Author), Marcelo Galarza (Author), A. Gatopoulou (Author), Giovanni Gazzeri (Author), Francesco Gianfagna (Author), Yuzuru Ikehara (Author), Seiji Ito (Author), S. Kashin (Author), P. Katsinelos (Author), Seigo Kitano (Author), Yasuhiro Kodera (Author), Dorothy C. Cardinni (Editor) This new book presents important leading-edge research on stomach cancer.Stomach cancer (also called gastric cancer ) is the growth of cancer cells in the lining and wall of the stomach. Stomach cancer represents roughly 2% (25,500) cases of all new cancer cases yearly in the United States, but it is much more common in Japan, Great Britain, South America, and Iceland. It is associated with high salt in the diet, smoking, and low intake of fruits and vegetables. Infection with H. pylori is the main risk factor in about 80% or more of gastric cancers. It is more common in men. A very small percentage of diffuse-type gastric cancers are thought to be genetic. Hereditary Diffuse Gastric Cancer (HDGC) has only recently been identified and research is ongoing, but genetic... |
| © 2009 BrightSurf.com |